Related references
Note: Only part of the references are listed.The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
Alex Spyropoulos
Therapeutics and Clinical Risk Management (2016)
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia
Mario Lapecorella et al.
BLOOD COAGULATION & FIBRINOLYSIS (2010)
Agents for the Treatment of Heparin-Induced Thrombocytopenia
Theodore E. Warkentin
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia
A. Ekbatani et al.
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA (2010)
Treatment of heparin-induced thrombocytopenia after cardiac surgery: Preliminary experience with fondaparinux
Federico Pappalardo et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive
S. Selleng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Unfractionated Heparin Dosing for Venous Thromboembolism in Morbidly Obese Patients: Case Report and Review of the Literature
April E Myzienski et al.
PHARMACOTHERAPY (2010)
The temporal profile of the anti-PF4/heparin immune response
Andreas Greinacher et al.
BLOOD (2009)
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients
Alexander G. G. Turpie et al.
BLOOD COAGULATION & FIBRINOLYSIS (2009)
Budd-Chiari syndrome and heparin-induced thrombocytopenia in polycythemia vera: Successful treatment with repeated TIPS and interferon alpha
Riad Akoum et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2009)
Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery 'spontaneous' HIT
R. K. Pruthi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia
T. Bakchoul et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Heparin Induced Thrombocytopenia and Re-Thrombosis Associated With Warfarin and Fondaparinux in a Child
Scott H. Maurer et al.
PEDIATRIC BLOOD & CANCER (2009)
HEPARIN-INDUCED THROMBOCYTOPENIA SUCCESSFULLY TREATED WITH FONDAPARINUX
S. Seldrum et al.
ACTA CLINICA BELGICA (2009)
Heparin-Induced Thrombocytopenia and Phlegmasia Cerulea Dolens of the Upper Limb Successfully Treated with Fondaparinux
Konstantinos Filis et al.
ACTA HAEMATOLOGICA (2008)
Standardizing the management of heparin-induced thrombocytopenia
Susan Fugate et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis
Khalid A. Alsaleh et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Heparin-induced thrombocytopenia: a historical perspective
John G. Kelton et al.
BLOOD (2008)
Treatment and prevention of heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
CHEST (2008)
Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of 'spontaneous' HIT?
R. M. Jay et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal
I. Elalamy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Can heparin-induced thrombocytopenia be associated with fondaparinux use? Reply to a rebuttal
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings
A. Greinacher et al.
THROMBOSIS RESEARCH (2008)
Cerebral venous thrombosis and heparin-induced thrombocytopenia in an 18-year old male with severe ulcerative colitis
Gudrun Scheving Thorsteinsson et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
Gregory K. Lo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Meta-analysis of venous thromboembolism prophylaxis in medically ill patients
Abir O. Kanaan et al.
CLINICAL THERAPEUTICS (2007)
Efficacy and safety of fondaparinux versus Enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial
Shamir R. Mehta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison
A. G. G. Turpie et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes
A. Greinacher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
BLOOD (2006)
Testing for heparin-induced thrombocytopenia antibodies
Theodore E. Warkentin et al.
TRANSFUSION MEDICINE REVIEWS (2006)
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: Case report and review of the literature
Shawnna L. Patterson et al.
PHARMACOTHERAPY (2006)
Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies
Andreas Greinacher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Heparin-induced thrombocytopenia
Gowthami M. Arepally et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Use of fondaparinux in a patient with anti phospholipid antibody syndrome and heparin-associated thrombocytopenia
S. G. Holtan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
AT Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
TE Warkentin et al.
BLOOD (2005)
Development of antibodies specific to polyanion-modified platelet factor 4 during treatment with fondaparinux
C Pouplard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Risk for heparin-induced thrombocytopenia. with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
N Martel et al.
BLOOD (2005)
Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin
MM Prechel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin
P Savi et al.
BLOOD (2005)
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia
L Rauova et al.
BLOOD (2005)
Use of fondaparinux (ARIXTRA®) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II
M Haase et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy
AGG Turpie
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Fondaparinux or Enoxaparin for the initial treatment of symptomatic deep venous thrombosis -: A randomized trial
HR Büller et al.
ANNALS OF INTERNAL MEDICINE (2004)
An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients
TE Warkentin et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Successful use of Arixtra® in a patient with paroxysmal nocturnal hemoglobinuria, Budd-Chiari syndrome and heparin-induced thrombocytopenia
EA D'Amico et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia
Y Gruel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin
TE Warkentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery - A meta-analysis of 4 randomized double-blind studies
AGG Turpie et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Delayed-onset heparin-induced thrombocytopenia
L Rice et al.
ANNALS OF INTERNAL MEDICINE (2002)
The pharmacokinetics of fondaparinux sodium in healthy volunteers
F Donat et al.
CLINICAL PHARMACOKINETICS (2002)
Delayed-onset heparin-induced thrombocytopenia and thrombosis
TE Warkentin et al.
ANNALS OF INTERNAL MEDICINE (2001)
Temporal aspects of heparin-induced thrombocytopenia
TE Warkentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
